Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.

Careful monitoring is crucial to prevent JC virus reactivation in lupus patients treated with rituximab.

Dauricine may help treat certain brain cancers by reducing cancer cell growth and promoting cell death.

The new nanoparticles could improve melanoma treatment by working better than current options.

Teriflunomide is safe and tolerable for treating relapsing-remitting multiple sclerosis, with manageable side effects.

Enhancing immune response can improve cancer treatment effectiveness.

Abrocitinib is being evaluated for safety and effectiveness in treating moderate to severe atopic dermatitis.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Oral dutasteride can potentially treat frontal fibrosing alopecia in postmenopausal women, with some patients showing disease arrest and hair regrowth.

Subcutaneous trastuzumab improves some symptoms and doesn't harm overall quality of life in breast cancer patients.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Farudodstat may effectively treat alopecia areata by protecting hair follicles without harmful effects.

Promising cancer treatments were found, but the manufacturer closed.

Bendamustine, often combined with other drugs, is effective and less toxic for certain blood cancers, but less effective for young, fit patients with CLL.

Farudodstat may help treat alopecia areata by protecting hair follicles.

BRAF inhibitors for melanoma often cause skin side effects, but they can be managed with proper care.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

Imiquimod improved skin pigmentation in most patients with xeroderma pigmentosum and may prevent further skin cancer, but some treatments can have side effects.

Dutasteride injections can help treat hair loss in men and women.

Anifrolumab improves quality of life and reduces steroid use in SLE patients.

Imuvert can prevent some chemotherapy-induced hair loss.

The new delivery method for dutasteride is more effective and has fewer side effects.

CDK4/6 inhibitors affect safety and quality of life differently, requiring careful use.

Rituximab may cause skin issues, but baricitinib can help improve them.

BLZ-100 is safe for use in skin cancer surgery and may help identify cancerous tissue.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

Dormant melanoma cells in mice interact minimally with memory T cells due to a suppressive tumor environment.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

Adalimumab significantly improved Hidradenitis Suppurativa and quality of life in two patients.

Mogamulizumab can cause hair loss and skin rashes.